[Takeda Pharmaceutical Company Limited Special Webinar] Pioneering the Future of Synthetic Molecule Process Development - Fully Automated Optimization Workflow through Autonomous HTE Lab

The SMPD division of Takeda Pharmaceutical Company has significantly evolved its high-throughput experimentation (HTE) and automation capabilities over the past few years. At the core of this evolution are the tools and devices from Unchained Labs, which offer high compatibility and enable an integrated comprehensive solution. Our ultimate goal is to build Self-Driving Labs (SDLs) that execute self-optimizing workflows utilizing AI and algorithms. Extensive parameter exploration is essential for process development and optimization, and iterative, data-driven SDLs demonstrate their true value, especially when combined with automated HTE synthesis platforms. In this webinar, we will present a vision for the future of fully automated optimization HTE workflows that can accommodate various applications in synthetic molecular pharmaceutical development. Additionally, we will delve into current success stories of existing hardware and software, as well as the challenges we face at this point through real-world examples.

Date and time | Friday, Sep 05, 2025 02:00 PM ~ 03:00 PM |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration